Clinical Trials Browser

INDUSTRY × Brain Neoplasms × gadoteridol × Clear all

NCT00522951 2017-08-28

SH L 562BB Phase II/III Dose Justification and Gadoteridol-controlled Comparative Study

Phase 3 Completed

165 enrolled 24 charts

Brain Neoplasms